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The gene coding for the HIV-l protease was cloned in an Escherichia coli expression vector adding three-histidine codons to the amino and carboxy 
terminus of the protease sequence. Expression of the protease from this construct led to the accumulation of high amounts of insoluble histidine- 
linked protease ntrapped in inclusion bodies. The histidine-linked protease could be efficiently released from purified inclusion bodies with 6 M 
guanidine hydrochloride and further purified by metal chelate affinity chromatography. The refolded protease cleaved synthetic peptide substrates 
and the viral polyprotein p55 with the same specificity as the wild type protease. It displays a specific activity of 4.4 pmol/min/mg. 
HIV-1 protease; Metal affinity chromatography; Acetyl-pepstatin 
1. INTRODUCTION 
The protease of human immunodeficiency virus type 
1 (HIV-1) is essential for the viral life cycle [1,2]. It 
processes the viral gag and gag-pol polyproteins to the 
mature structural and enzymatically active proteins [3]. 
Point mutations that inactivated the viral protease gave 
rise to the production of noninfectious progeny virus 
[1]. Due to this crucial role in the viral replication the 
HIV-1 protease is regarded as one of the most promis- 
ing targets for antiviral intervention [4]. Therefore, pro- 
duction and purification of large quantities of this en- 
zyme are prerequisites for the development of assays 
which allow the identification of potent and selective 
inhibitors. Several laboratories have described the pro- 
duction of HIV-1 protease ither by expression i  Esch- 
erichia coli or Saccharomyces cerevisiae [5 15] or by the 
chemical synthesis of the 99 amino acids-long monomer 
[14,16,17]. 
Here we report a method for expression and easy 
purification of large quantities of a recombinant histi- 
dine-linked HIV-1 protease in E. coli and a rapid and 
easy purification procedure for this enzyme. 
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2. MATERIALS AND METHODS 
2.1. Cloning and expression of the histidine-linked protease 
A BamHI-BgllI fragment coding for the HIV-1 protease was syn- 
thesized by amplifying the protease open reading frame of the HIV-1 
provirus harboring plasmid pNL 4.3 using the two primers shown in 
Fig. IA. This fragment was cloned in-frame in the BamHI BglII site 
of the IPTG-inducible E. coli expression vector pDS 56/3H-3H [18,19]. 
This expression vector provides a ATG start codon and three His 
codons upstream of the BamHI BglII site and another three terminal 
His codons downstream ofthe cloning site. The resulting plasmid pDS 
5613H-Hprt-3H was transformed into the E. coli strain MI5 contain- 
ing the lacl-producing repressor plasmid PDM 1 .I [20]. Transformants 
were selected on LB-agar plates supplemented with 25 ,ug/ml kanamy- 
cin and 100 ¢tg/ml ampicillin. Recombinant plasmids were identified 
by restriction endonuclease analysis and clones containing the correct 
sized insert were sequenced [21]. 
For induction of gene expression E. coil M15 PDMI.I containing 
plasmid pDS 5613H-Hprt-3H were grown at 37°C in 1 litre 2 x YT 
medium containing 25/lg/ml kanamycin and 100 ,ug/ml ampicillin. At 
an OD6o0 = 0.7 the culture was divided in 4 x 250 ml and IPTG added 
to a final concentration f 400 pg/ml. The cultures were induced for 
a period of up to 5 h. 
2.2. Purification and solubilization of histidine-linked protease contain- 
ing inclusion bodies 
The purification of inclusion bodies and the solubilization of the 
histidine-linked protease was performed using a modified protocol of 
a published procedure [22]. 
In short, cells were centrifuged and the pellet (9-l0 g/l) resuspended 
in 5 ml/g buffer A containing 50 mM Tris-HC1, 50 mM NaCI, 10 mM 
EDTA, 0.1 mM PMSF, pH 8.0. Lysozyme was added (1 mg/ml f.c.) 
and the cells were kept on ice for 30 rain and then frozen to -70°C. 
After thawing, NP-40 was added (0.25% (v/v) f.c.) followed by 20 min 
incubation on ice. DNase I (0.1 mg/ml f.c.) with MgC12 (10 mM f.c.) 
were added. This suspension was centrifuged at17,000 x g for 15 min 
in a Sorvall centrifuge using an SS34 rotor. The insoluble fraction was 
gently resuspended with a Pasteur pipette a  5ml/g in buffer A contain- 
ing 0.5% (v/v) Triton X-100, put on a table shaker for 30 min at room 
temperature and again collected by centrifugation (17,000 x g; 15 
min). The Triton-extraction step was repeated twice followed by a 
wash with an equal volume of deionized water. The pellet was resus- 
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pended at 5 mg/ml in buffer B (50 mM Tris-HC1, 50 mM NaC1, 6 M 
guanidine hydrochloride, pH 8.0). 
The inclusion bodies were solubilized overnight by gentle shaking. 
Samples were taken from all purification steps and analyzed by SDS- 
PAGE on 17% tricine-gels [23]. The separated protein bands were 
visualized either by Coomassie blue staining or by immunoblot tech- 
niques using a mouse monoclonal antibody raised against recombi- 
nant HIV-I protease. 
2.3. Nickel iminodiacetic acid affinity chromatography and renatura- 
tion of  the histidine-linked protease 
Iminodiacetic acid (IDA) adsorbent (Chelating Sepharose, Pharma- 
cia) charged with Ni 2÷ as described by Hochueli et al. [24] was packed 
into a column (7.5 cmx 1.6 cm) and equilibrated with buffer B. All 
chromatographic steps were performed at a flow rate of 20 ml/h. The 
solubilized inclusion bodies were loaded onto the Ni2+-IDA column 
and after extensive washing with buffer B, the bound material was 
eluted by an imidazole gradient ranging from 0-100 mM in buffer B. 
The chromatogram was monitored by UV detection at 280 nm and the 
collected fractions were analyzed by 17% tricine SDS-PAGE and 
Western blot analysis. Fractions containing pure histidine-linked pro- 
tease were diluted to a final protein concentration of 10 30/2g/ml, 
adjusted to 10 mM DTT and dialyzed for 24 h against 100 x volume 
of MTEG buffer (20 mM MES pH 6.0, 0.01% Triton X-100, 5 mM 
EDTA, 29% glycerol) supplemented with 10 mM DTT. Aliquots were 
stored at -70°C. 
2.4. Protease activi O, assay 
The specific activity of the histidine-linked protease was determined 
with the chromophoric substrate H-K-A-R-V-L-Nph-E-A-NIe-S. 
Proteolytic leavage of this substrate by the protease leads to the 
formation of an amino-terminal Nph fragment. The reaction mixture 
contained 8.4 nmol substrate, 20 mM MES pH 6.0 and 40 ng purified 
protease in a final volume of 100/21. After incubation at 37°C for 30 
min, proteolysis was stopped by the addition of 100/21 0.3 M HCIO4. 
For the determination of the Kin, substrate concentrations ranging 
from 1 to 50/2M in 0.1 M Na-acetate, 0.9 M NaC1, pH 4.7 were used. 
Reactions were started by the addition of 47.6 ng enzyme and the final 
assay volume was 200/21. After 45 rain incubation at 37°C proteolysis 
was stopped by addition of20/210.3 M HCIO 4. The assay mixture was 
analyzed by RP-HPLC using a Vydac C 18 column, equilibrated with 
22% acetonitrile, 78% H20 and 0.08% TFA at a flow rate of 1 ml/min. 
The formation of cleavage products was monitored at 280 nm. Kinetic 
constants were determined with less than 20% substrate turnover. 
Enzymatic activity of the histidine-linked protease was also tested, 
using HIV-1 p55 gag precursor protein expressed in E. coli. 300 ng 
partially purified HIV-1 gag polyprotein from bacterial ysates was 
incubated for 2 h in 20 mM MES buffer pH 6.0 containing 20 ng 
histidine-linked protease in a final volume of 20/21. The reaction was 
stopped by addition of an equal volume of 2 x sample buffer and the 
reaction mixture was applied to 12% SDS-polyacrylamide g l. After 
electrophoresis the proteins were transferred to immobilon and the 
blot was developed using an anti p24 mouse monoclonal antibody, 
recognizing also p55 and processing intermediates. 
3. RESULTS AND DISCUSSION 
3.1. Construction and expression of the histidine-linked 
protease in E. coli 
Fig. 1A shows the cloning strategy for the histidine- 
linked protease as described in section 2. It resulted in 
the construction of an IPTG-inducible gene coding for 
the 99 amino acids of the HIV-1 protease sequence 
preceded by an initiator methionine and eight addi- 
tional amino acids including three histidines 
(MRGSHHHGS-) and extended at the C terminus by 
arginine-serine followed by three histidines (-RSHHH) 
(Fig. 1B). The histidine-linked protease has a calculated 
molecular weight of 12.46 kDa. Extracts from induced 
and non-induced bacterial cultures containing the ex- 
pression vector pDS 56/3H-Hprt-3H were analyzed by 
SDS-PAGE. Induction by IPTG yielded a product 
which migrated at the expected position of 12.5 kDa 
(Fig. 2A, lane 2). The 12.5 kDa protein band was absent 
in either noninduced cells (lane 3) or non-transformed 
bacteria (lane 1). Western blot analysis (Fig. 2B) 
showed that the 12.5 kDa protein identified by Coomas- 
sie blue staining reacted specifically with a HIV-1 pro- 
tease specific antibody. Therefore, the 12.5 kDa protein 
represents he histidine-linked HIV-1 protease. The his- 
tidine-linked protease could be detected 15 min after 
induction and the amount increased until approxi- 
mately 60 min. Prolonged incubation until 5 h did not 
alter the yield significantly. But 5 h after induction a 
minor contamination probably corresponding to a trun- 
cated form of the protease could be detected. 
3.2. Purification and rejblding of the histidine-linked 
protease 
Bacterial lysate from cells collected 5 h after induc- 
tion was used for the purification of the protease. First, 
the distribution of the histidine-linked protease between 
the pellet fraction and the supernatant fraction was an- 
alyzed after centrifugation of the bacterial ysate at 
17,000 xg (see section 2). Western blot analysis re- 
vealed that approximately 90% of the expressed histi- 
dine-linked protease was in the insoluble fraction (Fig. 
3B, lane 1-3). Therefore, the insoluble fraction was used 
for further purification. 
By optimized washing procedures (i.e. 3 x Triton X- 
100, 1 X H20 ) the majority of contaminating bacterial 
proteins were removed from the insoluble material with- 
out loss of protease (lane 4-10). However, two major 
contaminants migrating at about 35 kDa and 15 kDa, 
respectively, remained in the insoluble fraction (lane 
11). Harsher mechanical treatment of pellets (i.e. 
vortexing) partially disrupted the inclusion bodies and 
led to loss of material (data not shown). Finally, the 
histidine-linked protease together with the two major 
contaminants could be completely solubilized from the 
purified inclusion bodies by 6 M guanidine hydrochlo- 
ride. No protease was left in the pellet of this fraction 
(Fig. 3B, lane 13). 
The fraction containing the solubilized histidine- 
linked protease was then loaded on the nickel affinity 
column equilibrated with 6 M GuHC1. Fig. 4B shows 
that the majority of contaminants could be found in the 
flow through (I), whereas the histidine-linked protease 
was efficiently bound to the column. Applying an imi- 
dazole gradient a split peak could be detected in the 
chromatogram (Fig. 4A). The first maximum, corre- 
sponding to fraction 24, contained mainly protein con- 
taminants, whereas the second maximum represented 
the highest concentration f the protease. Pure protease 
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IA) primer I 5' AAA GGA TCC CCT CAG ATC ACT CTr TGG C 3' 
primer II 5' AAA AGA TCT CAA CAC TTG CAG GGG CTG C Y 
primer I 
5' 3' 
[ PROTEASE RT ] 
pNL4.3 [ P6 ] y 5' 
PCR 
primer II 
[ AAA BamHI [ protease 297bp 
pDS/3H-3H 
BamHI,Bgl II 
l igation 
B.ml t l \ /  , , ~ / B g l  11 
P\O ~ ~. - . . . . . .~ .  top 
I B¢I:: i AAA[ 
Balm HI 
I [3) ATGAGAGGATCC.CATCACCATGGATCCCCTCAGATCACTCTTTGC,~AGCGACCCCTCGTC 6 0 
M R G S H H H G S P Q I T L W Q R P L V 
ACAATAAAGATA~AATTAAAGGAAGC TC TATTAGATACAGGAGCAGATGATACA 120 
T I K I G G Q L K E A L L D T G A D D T 
GTATTAGAAGAAATGAATTTGC CAGGAAGATGGAAACCAAAAATGATA~AATTGGA 180 
V L E E M N L P G R W K P K M I G G I G 
GGTTTTATCAAAGTAAGACAGTATGATCAGATAC TCATAGAAATC TGC GGACATAAAGC T 240 
G F I K V R Q Y D Q I L I E I C G H K A 
ATAGGTACAGTATTAGTAGGAC C TACAC C TGTCAACATAATTGGAAGAAATC TGTTGAC T 300 
I G T V L V G P T P V N I I G R N L L T 
Bgl II 
CAGATTGGC TGCAC TT  TAAATTTTAGATC TCAC CATCAC TAA 3 4 2 
Q A G C T L N F R S H H H 
Fig. 1. Cloning strategy for the histidine-linked HIV-1 protease. (A) The HIV-1 protease open reading frame in pNL4.3 was amplified by PCR 
using primer I and II. The resulting fragment was cloned into the BamHI-BglII site of the expression vector pDS/3H-3H. The amino acid sequence 
of the recombinant protein is depicted in B. 
was eluted starting from fraction 30. A single band with mated a purity of greater than 95% for the histidine- 
the expected molecular weight of 12.5 kDa could be linked protease. For renaturation samples of pure pro- 
identified in the silver stained gel (Fig. 4C). We esti- tease were diluted with buffer B to give a final protein 
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A) kD M + C 
47--~t! 
30 mai l  
19 ~ ........ ~ ..,,,,. 
~5 4 l l l l J~  ~ 
6 
3 
directed against he p24 capsid protein. As shown in 
Fig. 5, incubation of p55 gag without protease (lane C) 
left the p55 gag polyprotein i tact. In contrast, incuba- 
tion of p55 gag with purified histidine-linked protease 
processed the precursor p otein to the p24 capsid pro- 
tein and intermediates with a molecular weight of 31 
kDa and 41 kDa, respectively (lane 0). Addition of > 10 
¢zM acetyl-pepstatin, a specific inhibitor of aspartic pro- 
teases, abolished the proteolytic activity of the histidine- 
linked protease. Concentrations of 1 ~M or less resulted 
in only partial inhibition. 
The kinetic parameters of the histidine-linked pro- 
tease were determined using the chromophoric sub- 
strate H-K-A-R-V-L-Nph-F-Nle-S. This peptide mim- 
ics the cleavage site between the p24 capsid protein and 
the p6 nuclear capsid protein. The cleavage process wa
monitored by RP HPLC. 
B) kD M 
47 
30 ~,~,. 
19 ~ .{~,~ 
15 4'~' 
3 ~,;, 
0' 15' 30' 60' 90' 2h 3h 5h 20h 
Fig. 2. Expression of the histidine-linked protease. (A) Extracts from 
bacterial cultures containing the expression vector pDS56/3H-Hprt- 
3H before (-)  or after (+) induction or from cultures without the 
expression vector (c) were analysed by PAGE and Coomassie blue 
staining. (B) Time course of expression for the histidine-linked pro- 
tease. Western blot analysis of bacterial extracts drawn at various time 
points after IPTG induction. Lane M contains molecular weight size 
markers. 
concentration f 10-30/zg/ml. This protein concentra- 
tion proved to be optimal for dialysis. At higher protein 
concentrations precipitates formed during dialysis and 
the specific activity decreased (data not shown). The 
refolded histidine-linked protease could be stored at 
-70°C for several weeks without considerable oss of 
activity. 
3.3. Enzymatic activity of the purified histidine-linked 
protease 
First, we tested the histidine-linked protease in its 
ability to cleave an endogenous substrate. Therefore, 
partially purified p55 gag precursor protein was incu- 
bated with purified protease and the reaction monitored 
by Western blot analysis using a monoclonal antibody 
A) 
Triton-wash ] H20 IGuHCI 
1 x 2x 3x I 
kD M L S P S P S P S P S P [S  P 
L2 u ~ 
47 _am=Be=a= 
3o 
19 . . . IH  
6 ,~ 
3 
B) 
kD 
47 
30 
19 
15 
M L S P 
l Triton-wash ] H20 GuHCI 
lx  2x 3x 
S P S P S P S P S P 
w ~ U 41m m 
3 
Fig. 3. Purification of inclusion bodies containing the histidine-linked 
protease. (A) Western blot analysis of aliquots from the purification 
procedure outlined in section 2. From left to right: the whole bacterial 
lysate (L), or the supernatant (S) and the pellet fraction (P) after the 
17,000 x g centrifugation; the supernatant (S) and the pellet (P) frac- 
tions after each of three repetitive Triton X-100 washes, one water 
wash and the final solubilisation in GuHCI. (B) Coomassie blue- 
stained gel of the identical samples after PAGE. Lane M contains 
molecular weight size markers. 
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Fig. 4. Affinity chromatography on nickel-loaded chelating Sepharose column. (A) UV absorbance profile of the guanidinium-HC1 solubilized 
material after chromatography on the affinity column. Fraction I indicates the flowthrough. Fractions 20 to 37 contained material eluted in the 
presence of increasing amounts of imidazole and was analysed by PAGE. (B) Coomassie blue-stained gel analysing fraction 20 to 37. (C) Silver 
stained gel analysing fraction 33 to 35. Lane M contains molecular weight size markers. 
strength was determined to be optimal without adding 
salt. 
Therefore, 20 mM MES buffer pH 6.0 was selected 
for the determination of the specific activity of the en- 
zyme. Under these conditions, the specific activity of the 
refolded enzyme was measured to be 4.4/tmol/min/mg. 
This compares well to the specific activity of the wild 
type enzyme, as published by others [12,15,22,25 27]. 
The Km for the chromophoric peptide could not be 
Fig. 6 shows the pH dependence of the proteolytic 
activity for the histidine-linked protease in the MES 
buffer system. The proteolytic activity was only slightly 
affected between pH 4.5 and 6.0 but dropped consider- 
ably at higher pH. This pH dependence of the histidine- 
linked protease is slightly different compared to the wild 
type HIV-1 protease. The wild-type protease is more 
sensitive to pH changes between 4.0 and 6.0 with a 
narrow optimum at pH 6.0 (data not shown). The ionic 
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pM acetylpepstatin 
kD M C 0 100 10 1 0.1 0.01 
111 
71 
44 
28 
,~ "~ - P24 
18 
15 
Fig. 5. Processing of p55 gag by purified histidine-linked HIV-1 protease 
in the presence of acetyl-pepstatin. Western blot analysis; from left to 
right: 300 ng partially purified p55 gag poly protein were incubated 
without (C) enzyme, enzyme without inhibitor (0), or decreasing 
amounts (100 to 0.01/IM) of acetyl pepstatin. Lane M contains molec- 
ular weight size markers. Positions of the p55 poly protein and the 
cleavage product p24 are indicated. 
determined with the hist id ine- l inked protease in the 
MES buffer system because the enzymat ic  activity of  the 
enzyme was unaffected over a substrate concent rat ion  
range of  1 50 HM. The Km was therefore determined in 
0.1 M Na-acetate,  0.9 M NaC1 buffer pH 4.7. Us ing 
double  reciprocal L ineweave~Burk  plot  a Km of  51 / IM 
was calculated for the peptide substrate using the histi- 
d ine- l inked protease. It has to be emphasized that the 
specific activity is 8-fold lower in the Na-acetate buffer 
system when compared  with the MES buffer system. 
Many  invest igators studied the substrate affinity of  
the authent ic  HIV-1 protease purif ied by var ious purif i- 
cat ion procedures.  The chromophor ic  peptide was iden- 
tified with a high Vm,x/Km and the Km was reported to 
be 21 / IM [28]. Therefore, the hist id ine- l inked HIV-1 
protease shows enzymat ic  haracterist ics s imilar to the 
wild type enzyme. 
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Fig. 6. pH-optimum of the histidine-linked HIV-I protease, pH de- 
pendence of the protease between pH 4 and 7. 
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